
Incyte Corporation INCY
$ 98.59
-0.51%
Quarterly report 2026-Q1
added 04-28-2026
Incyte Corporation EV/EBITDA Ratio 2011-2026 | INCY
Annual EV/EBITDA Ratio Incyte Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 | -85.2 | 29.2 | 75.3 | -98.2 | 104 | 232 | -9.37 K | -680 | 1.27 K | -21.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 K | -9.37 K | -775 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-14.9 | $ 9.32 | 1.19 % | $ 603 M | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
29.4 | $ 0.89 | 0.51 % | $ 6.54 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-21.1 | $ 22.48 | 1.26 % | $ 3.73 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Innoviva
INVA
|
3.07 | $ 23.09 | 0.17 % | $ 1.56 B | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
4.1 | $ 104.34 | 2.72 % | $ 27.2 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-5.59 | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Innate Pharma S.A.
IPHA
|
-6.65 | $ 1.45 | -2.03 % | $ 235 M | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 2.95 | -1.34 % | $ 4.86 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
Applied Therapeutics
APLT
|
-0.476 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
Aquestive Therapeutics
AQST
|
-7.26 | $ 4.08 | 0.74 % | $ 436 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.807 | - | 17.91 % | $ 11.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.86 | $ 22.96 | 2.64 % | $ 2.92 B | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Edesa Biotech
EDSA
|
-1.27 | $ 15.11 | -4.97 % | $ 48.3 M | ||
|
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.44 | 1.77 % | $ 383 M | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | - | - | $ 96.9 B | ||
|
Evogene Ltd.
EVGN
|
-1.31 | $ 0.76 | -0.42 % | $ 27.9 M | ||
|
Atreca
BCEL
|
-2.76 | - | -11.76 % | $ 5.79 M | ||
|
BioDelivery Sciences International
BDSI
|
8 | - | -4.8 % | $ 255 M | ||
|
Exelixis
EXEL
|
18.1 | $ 45.14 | 1.01 % | $ 12.3 B |